Literature DB >> 32102902

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.

Charlotte H Coles1, Rachel M Mulvaney1, Sunir Malla1, Andrew Walker1, Kathrine J Smith2, Angharad Lloyd1, Kate L Lowe1, Michelle L McCully1, Ruth Martinez Hague1, Milos Aleksic1, Jane Harper1, Samantha J Paston1, Zoe Donnellan1, Fiona Chester1, Katrin Wiederhold1, Ross A Robinson1, Andrew Knox1, Andrea R Stacey1, Joseph Dukes1, Emma Baston1, Sue Griffin2, Bent K Jakobsen1, Annelise Vuidepot1, Stephen Harper3.   

Abstract

The molecular rules driving TCR cross-reactivity are poorly understood and, consequently, it is unclear the extent to which TCRs targeting the same Ag recognize the same off-target peptides. We determined TCR-peptide-HLA crystal structures and, using a single-chain peptide-HLA phage library, we generated peptide specificity profiles for three newly identified human TCRs specific for the cancer testis Ag NY-ESO-1157-165-HLA-A2. Two TCRs engaged the same central peptide feature, although were more permissive at peripheral peptide positions and, accordingly, possessed partially overlapping peptide specificity profiles. The third TCR engaged a flipped peptide conformation, leading to the recognition of off-target peptides sharing little similarity with the cognate peptide. These data show that TCRs specific for a cognate peptide recognize discrete peptide repertoires and reconciles how an individual's limited TCR repertoire following negative selection in the thymus is able to recognize a vastly larger antigenic pool.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32102902      PMCID: PMC7086387          DOI: 10.4049/jimmunol.1900915

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  A direct estimate of the human alphabeta T cell receptor diversity.

Authors:  T P Arstila; A Casrouge; V Baron; J Even; J Kanellopoulos; P Kourilsky
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions.

Authors:  E Krissinel; K Henrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues.

Authors:  Laurent Derré; Marc Bruyninx; Petra Baumgaertner; Mathias Ferber; Daphné Schmid; Antoine Leimgruber; Vincent Zoete; Pedro Romero; Olivier Michielin; Daniel E Speiser; Nathalie Rufer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

6.  High-quality full-length immunoglobulin profiling with unique molecular barcoding.

Authors:  M A Turchaninova; A Davydov; O V Britanova; M Shugay; V Bikos; E S Egorov; V I Kirgizova; E M Merzlyak; D B Staroverov; D A Bolotin; I Z Mamedov; M Izraelson; M D Logacheva; O Kladova; K Plevova; S Pospisilova; D M Chudakov
Journal:  Nat Protoc       Date:  2016-08-04       Impact factor: 13.491

Review 7.  Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours.

Authors:  Kate L Lowe; David Cole; Rupert Kenefeck; Ita OKelly; Marco Lepore; Bent K Jakobsen
Journal:  Cancer Treat Rev       Date:  2019-06-12       Impact factor: 12.111

8.  An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.

Authors:  Jane Harper; Katherine J Adams; Giovanna Bossi; Debbie E Wright; Andrea R Stacey; Nicole Bedke; Ruth Martinez-Hague; Dan Blat; Laure Humbert; Hazel Buchanan; Gabrielle S Le Provost; Zoe Donnellan; Ricardo J Carreira; Samantha J Paston; Luise U Weigand; Martina Canestraro; Joseph P Sanderson; Sophie Botta Gordon-Smith; Kate L Lowe; Karolina A Rygiel; Alex S Powlesland; Annelise Vuidepot; Namir J Hassan; Brian J Cameron; Bent K Jakobsen; Joseph Dukes
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

9.  Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.

Authors:  Kevin Michael Boehm; Bhavneet Bhinder; Vijay Joseph Raja; Noah Dephoure; Olivier Elemento
Journal:  BMC Bioinformatics       Date:  2019-01-05       Impact factor: 3.169

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  11 in total

1.  Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.

Authors:  Christopher J Holland; Rory M Crean; Johanne M Pentier; Ben de Wet; Angharad Lloyd; Velupillai Srikannathasan; Nikolai Lissin; Katy A Lloyd; Thomas H Blicher; Paul J Conroy; Miriam Hock; Robert J Pengelly; Thomas E Spinner; Brian Cameron; Elizabeth A Potter; Anitha Jeyanthan; Peter E Molloy; Malkit Sami; Milos Aleksic; Nathaniel Liddy; Ross A Robinson; Stephen Harper; Marco Lepore; Chris R Pudney; Marc W van der Kamp; Pierre J Rizkallah; Bent K Jakobsen; Annelise Vuidepot; David K Cole
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

2.  TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs.

Authors:  Koshlan Mayer-Blackwell; Stefan Schattgen; Liel Cohen-Lavi; Jeremy C Crawford; Aisha Souquette; Jessica A Gaevert; Tomer Hertz; Paul G Thomas; Philip Bradley; Andrew Fiore-Gartland
Journal:  Elife       Date:  2021-11-30       Impact factor: 8.140

3.  Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy.

Authors:  Philip C Simister; Ellen C Border; João F Vieira; Nicholas J Pumphrey
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

4.  NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.

Authors:  Mikiya Ishihara; Shigehisa Kitano; Shinichi Kageyama; Yoshihiro Miyahara; Noboru Yamamoto; Hidefumi Kato; Hideyuki Mishima; Hiroyoshi Hattori; Takeru Funakoshi; Takashi Kojima; Tetsuro Sasada; Eiichi Sato; Sachiko Okamoto; Daisuke Tomura; Ikuei Nukaya; Hideto Chono; Junichi Mineno; Muhammad Faris Kairi; Phuong Diem Hoang Nguyen; Yannick Simoni; Alessandra Nardin; Evan Newell; Michael Fehlings; Hiroaki Ikeda; Takashi Watanabe; Hiroshi Shiku
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 5.  Engineering the T cell receptor for fun and profit: Uncovering complex biology, interrogating the immune system, and targeting disease.

Authors:  Aaron M Rosenberg; Brian M Baker
Journal:  Curr Opin Struct Biol       Date:  2022-03-25       Impact factor: 7.786

6.  Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes.

Authors:  Ruslan Gibadullin; Caleb J Randall; John Sidney; Alessandro Sette; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2021-04-21       Impact factor: 15.419

7.  Targeting a neoantigen derived from a common TP53 mutation.

Authors:  Emily Han-Chung Hsiue; Katharine M Wright; Jacqueline Douglass; Michael S Hwang; Brian J Mog; Alexander H Pearlman; Suman Paul; Sarah R DiNapoli; Maximilian F Konig; Qing Wang; Annika Schaefer; Michelle S Miller; Andrew D Skora; P Aitana Azurmendi; Michael B Murphy; Qiang Liu; Evangeline Watson; Yana Li; Drew M Pardoll; Chetan Bettegowda; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Sandra B Gabelli; Shibin Zhou
Journal:  Science       Date:  2021-03-01       Impact factor: 47.728

8.  Characterization of amino acid residues of T-cell receptors interacting with HLA-A*02-restricted antigen peptides.

Authors:  Ying Zhu; Changxin Huang; Meng Su; Zuanmin Ge; Lanlan Gao; Yanfei Shi; Xuechun Wang; Jianfeng Chen
Journal:  Ann Transl Med       Date:  2021-03

9.  In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma.

Authors:  Qi Liu; Ye Tian; Yanyan Li; Wei Zhang; Wenxuan Cai; Yaju Liu; Yuefei Ren; Zhaoduan Liang; Peipei Zhou; Yajing Zhang; Yifeng Bao; Yi Li
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

10.  T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.

Authors:  Ziwei Chen; Pinglang Ruan; Lili Wang; Xinmin Nie; Xuejun Ma; Yurong Tan
Journal:  J Cell Mol Med       Date:  2020-12-15       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.